Global Patient Blood Management Market By Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic & Testing Instruments, Blood Storage Devices, Accessories, Syringes & Needles, Vials & Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Share Forecast to 2027
Market Analysis and Insights: Global Patient Blood Management Market
Patient blood management market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 17.6 billion by 2027 growing at a CAGR of 7.00% in the above-mentioned forecast period. The accelerating demand of blood across the globe for enumerable causes and needs amidst the prevailing ratio of blood diseases namely leukaemia has catered strategic market base for the patient blood management both in terms of volume and revenue.
The heightened encouragement for the value of donated blood through the various verticals of healthcare infrastructure, life sciences, placenta research, and hemoglobin for the advancement of medical industry hidden in the life saving entity (blood) has catapulted the dimensional growth of the patient blood management market during the forecast period of 2020 to 2027. Increment in the growth of blood donors and lucrative assistance offered in exchange of donating the blood is growing at strong pace. Within this succession the rapid growth of awareness brought by mushrooming blood donation camps has taken the patient blood management market toward the upside on the success graph owing to the real time solution provided. Accelerating pervasiveness of target viruses and forthcoming technological amendments is giving the optimum thrust in the market growth of the patient blood management market.
During the surging period of market expansions patient blood management industry is exposed to the certain restraining factors such as expensive quotients linked with procuring automated channel for patient blood management risk of data loss these factors can act as the restraints for the market growth. To overcome the certain curbing features, familiarity of safe and secure donated blood transmission and usage with the market penetration in the emerging economies will act as the opportunity for the market growth.
This patient blood management market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on patient blood management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Patient Blood Management Market Scope and Market Size
Patient blood management market is segmented on the basis of articles, unit and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of unit, the patient blood management market is segmented into blood components and whole blood.
- On the basis of articles, the patient blood management market is fragmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bank and transfusion software, software, assay kits, slide staining, blood typing reagents, culture media, reagents and kits, and blood bags.
- On the basis of end user, the patient blood management market is bifurcated into hospitals and blood banks.
Patient Blood Management Market Country Level Analysis
Patient blood management market is analysed and market size insights and trends are provided by country, articles, unit and end user as referenced above.
The countries covered in the patient blood management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
United States dominates the patient blood management market in the North America due to the eminent healthcare infrastructure, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2020 to 2027 due to the focus of various established market players to expand their presence in this particular region and encouraging repayment norms. Exceeding pool of aged and geriatric individuals in Europe will propel the blood transfusion demand hence will accelerate the market potential of patient blood management market.
The country section of the patient blood management market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Patient blood management market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for patient blood management market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the patient blood management market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Patient Blood Management Market Share Analysis
Patient blood management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to patient blood management market.
The major players covered in the patient blood management market report are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor, Inc., B. Braun Melsungen AG, Maco Pharma SAS, bioMérieux SA, KANEKA CORPORATION, Bio-Rad Laboratories, Inc., Abbott, Grifols, S.A., F. Hoffmann-La Roche Ltd, LivaNova PLC , among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analyst understands competitive strengths and provides competitive analysis for each competitor separately.
Customization Available: Global Patient Blood Management Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.